Repros Reported Interim Results From The Impact of Androxal; Alnylam Added Orphan Drug Status for ALN-AT3 Print E-mail
By Staff and Wire Reports   
Tuesday, 20 August 2013 19:49
Below is a look at some of the

Error. Page cannot be displayed. Please contact your service provider for more details. (6)

headlines for companies that made news in the healthcare sector on August 20, 2013.
Read more...
 
GTx Shares Halted After Reports of Poor Results for Enobosarm POWER Trials, Supernus Reports Final FDA Approval of Trokendi XR Print E-mail
By Staff and Wire Reports   
Monday, 19 August 2013 19:47
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 19, 2013.
Read more...
 
Cardica Issues MicroCutter XCHANGE 30 510(k) Application; Cadence Comments on USPTO's Reexamination of Patent Print E-mail
By Staff and Wire Reports   
Friday, 16 August 2013 18:31
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 16, 2013.
Read more...
 
Medtronic Issues First PMA Module for IN.PACT Balloon; St. Jude Announces Approval and First Use of Ablation Catheters Print E-mail
By Staff and Wire Reports   
Thursday, 15 August 2013 19:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 15, 2013.
Read more...
 
Our BioPharma Catalyst Watch List Print E-mail
By Scott Matusow   
Thursday, 15 August 2013 07:47
This week we list four biopharmaceutical companies that have upcoming catalysts. We expect these company's stock prices to appreciate significantly in the short term as they draw closer their respective catalysts.
Read more...
 
Upcoming Catalyst Could Spark Another Run for Insmed Print E-mail
By Scott Matusow   
Thursday, 15 August 2013 07:08
Sometimes in the biotechnology sector one company can provide investors with multiple opportunities to make money while limiting risk.
Read more...
 
Forest Labs and Almirall Delays NDA Filing for Aclidinium/formoterol Combination; Ampio Announces Ampion Study Meets Primary Endpoint Print E-mail
By Staff and Wire Reports   
Wednesday, 14 August 2013 19:20
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 14, 2013.
Read more...
 
Eli Soaring After Positive Cancer Drug Data; Osiris Reports Strong Efficacy for Grafix Print E-mail
By Staff and Wire Reports   
Tuesday, 13 August 2013 19:29
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 13, 2013.
Read more...
 
Avanir Announces Diabetes Co-Promotion Agreement with Merck; Celldex Announces Expansion of Phase 2 ReACT Study Print E-mail
By Staff and Wire Reports   
Monday, 12 August 2013 19:37
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 12, 2013.
Read more...
 
Red Acre Investments - Week Ending August 9, 2013 Print E-mail
By Red Acre Investments   
Sunday, 11 August 2013 22:23
 It's been a super busy week with so many mid-cap and small-cap biotech names filing earnings and holding Q2 conference calls. Catching our attention this week in particular were the speculative run in Inovio, Mannkind earnings, Immunocellular earnings, Synergy's End of Phase 2 meeting, spinoff and
earnings, and Amarin earnings and short interest. Let's go over these stories.
Read more...
 
<< Start < Prev 21 22 23 24 25 26 27 28 29 30 Next > End >>

Page 24 of 55
BMR:1